Levomilnacipran | |||
---|---|---|---|
Synonyms | F-2695 | ||
Brand names | Fetzima | ||
IUPAC name |
| ||
ChemSpider | |||
DrugBank | |||
PubChem | |||
PDB fields |
N/A | ||
Formula |
C15H22N2O | ||
InChI |
| ||
InChIKey |
| ||
SMILES |
| ||
Mol. mass |
246.3480 g/mol |
Levomilnacipran is the (1S,2R)-enantiomer of milnacipran and a serotonin-noradrenaline reuptake inhibitor that is used in the treatment of depression. It was first FDA approved on the 25th of July 2013.
External links[]
- NCBI Bookshelf provides free book resources on this topic.
- PubMed provides review articles from the past five years (limit to free review articles or to systematic reviews)
- The TRIP database provides clinical publications about evidence-based medicine.
Notes[]
Reference list[]
Antidepressants (ATC: N06A) | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
First-generation |
| ||||||||||||||||||||||||||||||||||
Second-generation |
|